Company

Ryan Beal, M.D.

Ryan Beal, M.D. is a serial entrepreneur focused on biopharma drug delivery innovation. He is recognized for his ability to leverage his scientific, R&D, and clinical acumen with a creative strategic and commercial mind. He has been involved with the launch of medical products with collective annual peak sales over $50 billion and been involved with the founding of multiple healthcare companies. Prior to his entrepreneurial endeavors, Ryan spent 7 years with McKinsey & Company where he was a leader in their Pharmaceutical Practice. He earned an M.D. with honors from the University of Pennsylvania School of Medicine and a BA with honors in Biophysical Chemistry from Dartmouth College.

Philippe Schaison, PharmD

Philippe Schaison is a respected leader in aesthetics with over 20 years of extensive experience in the skin care and aesthetics industries. Philippe joined Dyve’s Board of Directors in 2018 and he serves on a number of boards in the pharmaceutical and medical space, including Sientra, SENTÉ, and the Galien Foundation. Previously, he served as the former CEO of Syneron Candela North America and Global Executive Vice President Strategy and Business Development. He also served as President of Allergan US Aesthetic and Dermatology, leading the U.S. Aesthetic and Dermatology business ($2+ billion in sales), including Allergan's top aesthetic franchises: Botox, Juvederm, Kybella and SkinMedica. He has also held leadership roles with several other aesthetic businesses, including Clarins, Johnson & Johnson, and L’Oréal. Philippe has a Master of Business Administration in Marketing from the Hautes Etudes Commerciales (H.E.C.) in Paris, and a Doctorate in Pharmacy from the University of Paris V.

Aya Jakobovits, Ph.D.

Aya Jakobovits, Ph.D. has over 25 years track record in starting and growing biotech companies, which developed novel technologies and therapeutic products and brought over $14 billion to its shareholders. She founded Adicet Bio, Inc. in 2014 and served as its President and CEO until March 2018. She served as a Venture Partner at OrbiMed from 2011-2016. Previously, from 2010-2013, Dr. Jakobovits served as the President and Founding CEO of Kite Pharma, Inc., acquired in 2017 by Gilead for $11.9 billion. Before joining Kite Pharma, she served as Executive Vice President, Head of Research and Development at Agensys, Inc., an affiliate of Astellas Pharma Inc. Before Agensys acquisition by Astellas in 2007 for over $500 million, Dr. Jakobovits served as Agensys’ Senior Vice President, Technology and Corporate Development and Chief Scientific Officer and led its R&D, clinical and corporate development operations. Prior to Agensys, she served as the Director, Discovery Research and Principal Scientist at Abgenix, Inc., which was spun out of Cell Genesys, Inc. and based on the XenoMouse® technology developed under her leadership. Abgenix was acquired by Amgen Inc. for $2.2 billion.

Rajit Malhotra, MBA, MPA

Rajit Malhotra is the co-founder and Executive Chairman of Dyve. Rajit has 25 years of experience as an entrepreneur, investor and consultant. Rajit spent 14 years at McKinsey, predominantly in the Pharma and Biotech Practice while also serving as the Managing Partner of the Southern California Practice. Prior to McKinsey, he co-founded Shantha Biotech, an Indian biotech and vaccine company which was acquired by Sanofi in 2009 for $850M. Rajit is a Venture Partner at Peak State Ventures, a technology focused mid-stage venture fund. Rajit has undergraduate degrees from the College and the Wharton School of Business at the University of Pennsylvania, an MBA from the Kellogg School at Northwestern and an MPA/ID from the Kennedy School at Harvard University.